bioRxiv·19 AugOral administration of 1,10-phenanthroline-5-amine (PAA) significantly reduced amyloid plaque burden compared with untreated APP/PS1 micePreprint: experiments in animalsInterventionsPaper
AAIC 2025 Abstract·26 DecNovel properties of phenanthroline‐amine include binding to amyloid plaques and suppressing plaque growth in APP/PS1 mouse model of Alzheimer’s disease (AD)Experiments in animalsMechanismsPaper